Показано 0 из 0
Дата |
---|
03.05.2024 |
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
0.5746
|
0.6099
|
0.561
|
0.5368
|
0.609
|
0.6024
|
|
|
8 544.33
|
31.00
|
0.53
|
0.58
|
0.519
|
0.5105
|
0.5769
|
0.561
|
|
|
3 459.41
|
27.00
|
0.54
|
0.55
|
0.589
|
0.551
|
0.617
|
0.551
|
|
|
36 834.24
|
61.00
|
0.5651
|
0.62
|
0.622
|
0.542
|
0.622
|
0.565
|
|
|
2 087.64
|
20.00
|
0.57
|
0.609
|
0.60
|
0.5855
|
0.60
|
0.5855
|
|
|
4 025.08
|
16.00
|
0.59
|
0.64
|
0.6034
|
0.57
|
0.61
|
0.61
|
|
|
3 504.21
|
20.00
|
0.6151
|
0.638
|
0.5835
|
0.571
|
0.6466
|
0.6398
|
|
|
5 430.63
|
31.00
|
0.61
|
0.6347
|
0.6262
|
0.60
|
0.6496
|
0.62
|
|
|
9 904.45
|
114.00
|
0.645
|
0.6666
|
0.6538
|
0.606
|
0.6699
|
0.6698
|
|
|
18 706.73
|
130.00
|
0.583
|
0.639
|
0.52685
|
0.508
|
0.73
|
0.6349
|
|
|
60 971.80
|
385.00
|
Kineta, Inc. is a clinical-stage bio-pharmaceutical company. The Company focuses on the discovery and development of adaptive immunity and T cell therapies for the treatments for neuro-degenerative diseases. Kineta operates in the United States.